1. Home
  2. SCLX vs JRSH Comparison

SCLX vs JRSH Comparison

Compare SCLX & JRSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCLX
  • JRSH
  • Stock Information
  • Founded
  • SCLX 2011
  • JRSH 2016
  • Country
  • SCLX United States
  • JRSH United States
  • Employees
  • SCLX N/A
  • JRSH 5600
  • Industry
  • SCLX Biotechnology: Pharmaceutical Preparations
  • JRSH Apparel
  • Sector
  • SCLX Health Care
  • JRSH Consumer Discretionary
  • Exchange
  • SCLX Nasdaq
  • JRSH Nasdaq
  • Market Cap
  • SCLX 33.9M
  • JRSH 41.2M
  • IPO Year
  • SCLX N/A
  • JRSH 2018
  • Fundamental
  • Price
  • SCLX $5.70
  • JRSH $3.28
  • Analyst Decision
  • SCLX Strong Buy
  • JRSH Strong Buy
  • Analyst Count
  • SCLX 3
  • JRSH 1
  • Target Price
  • SCLX $367.50
  • JRSH $4.00
  • AVG Volume (30 Days)
  • SCLX 125.0K
  • JRSH 68.6K
  • Earning Date
  • SCLX 08-12-2025
  • JRSH 06-23-2025
  • Dividend Yield
  • SCLX N/A
  • JRSH 6.07%
  • EPS Growth
  • SCLX N/A
  • JRSH N/A
  • EPS
  • SCLX N/A
  • JRSH N/A
  • Revenue
  • SCLX $50,710,000.00
  • JRSH $145,812,006.00
  • Revenue This Year
  • SCLX $107.00
  • JRSH $13.06
  • Revenue Next Year
  • SCLX $82.52
  • JRSH $10.57
  • P/E Ratio
  • SCLX N/A
  • JRSH N/A
  • Revenue Growth
  • SCLX 7.79
  • JRSH 24.43
  • 52 Week Low
  • SCLX $3.60
  • JRSH $2.68
  • 52 Week High
  • SCLX $78.05
  • JRSH $4.17
  • Technical
  • Relative Strength Index (RSI)
  • SCLX 49.86
  • JRSH 52.10
  • Support Level
  • SCLX $4.53
  • JRSH $3.03
  • Resistance Level
  • SCLX $5.60
  • JRSH $3.43
  • Average True Range (ATR)
  • SCLX 0.41
  • JRSH 0.11
  • MACD
  • SCLX 0.01
  • JRSH 0.01
  • Stochastic Oscillator
  • SCLX 31.96
  • JRSH 58.54

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

About JRSH Jerash Holdings (US) Inc.

Jerash Holdings (US) Inc along with its subsidiaries is a manufacturer and exporter of customized, ready-made sport and outerwear from knitted fabric from its production facilities in Jordan. The company manufactures for retailers namely Walmart, Costco, Sears, Hanes, Columbia, Land's End, VF Corporation, and Philip-Van Heusen which owns brands such as The North Face, Nautica, Timberland, Wrangler, Lee, Jansport, Calvin Klein, Tommy Hilfiger, IZOD, Speedo etc. It derives its revenue from the manufacturing and sales of outerwear in the United States. The company's product offering consists of jackets, polo shirts, crew neck shirts, pants, and shorts made from knitted fabric. Geographically, the company generates maximum revenue from the United States.

Share on Social Networks: